Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014


#225036

71pages

GlobalData

$ 2500

In Stock


GlobalData's clinical trial report, Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014" provides data on the Ischemia Reperfusion Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemia Reperfusion Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemia Reperfusion Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables4
List of Figures 5

Introduction 6
Ischemia Reperfusion Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Ischemia Reperfusion Injury to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Ischemia Reperfusion Injury to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Ischemia Reperfusion Injury 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Ischemia Reperfusion Injury Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Ischemia Reperfusion Injury 32
Jul 01, 2014: Quark Announces Completion of Phase II Trial Evaluating QPI-1002 for Prevention of Delayed Graft Function in Kidney Transplant Patients 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Ikaria Holdings, Inc. 33
Clinical Trial Overview of Ikaria Holdings, Inc. 33
Trophos SA 34
Clinical Trial Overview of Trophos SA 34
Stealth Peptides Inc. 35
Clinical Trial Overview of Stealth Peptides Inc. 35
Prolong Pharmaceuticals 36
Clinical Trial Overview of Prolong Pharmaceuticals 36
Minapharm Pharmaceuticals & Chemical Industries 37
Clinical Trial Overview of Minapharm Pharmaceuticals & Chemical Industries 37
Ischemix 38
Clinical Trial Overview of Ischemix 38
Catalyst Biosciences, Inc. 39
Clinical Trial Overview of Catalyst Biosciences, Inc. 39
C. H. Boehringer Sohn AG & Co. KG 40
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 40
Apeptico Forschung und Entwicklung GmbH 41
Clinical Trial Overview of Apeptico Forschung und Entwicklung GmbH 41
Clinical Trial Overview of Top Institutes / Government 42
Radboud University 42
Clinical Trial Overview of Radboud University 42
Medical University of Vienna 43
Clinical Trial Overview of Medical University of Vienna 43
Ludwig-Maximilians-Universitat Munich 44
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 44
Istituto Clinico Humanitas 45
Clinical Trial Overview of Istituto Clinico Humanitas 45
Academic Medical Center 46
Clinical Trial Overview of Academic Medical Center 46
Regina Elena Cancer Institute 47
Clinical Trial Overview of Regina Elena Cancer Institute 47
South Australian Health and Medical Research Institute 48
Clinical Trial Overview of South Australian Health and Medical Research Institute 48
Herlev Hospital 49
Clinical Trial Overview of Herlev Hospital 49
University of Pittsburgh 50
Clinical Trial Overview of University of Pittsburgh 50
Karolinska Institute 51
Clinical Trial Overview of Karolinska Institute 51
Five Key Clinical Profiles 52

Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials by Region, 2014* 7
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Ischemia Reperfusion Injury Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Ischemia Reperfusion Injury to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Ischemia Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Ischemia Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Ischemia Reperfusion Injury to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Ischemia Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Ischemia Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Ischemia Reperfusion Injury Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Ischemia Reperfusion Injury Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Ischemia Reperfusion Injury Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Ischemia Reperfusion Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Holdings, Inc., 2014* 33
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Trophos SA, 2014* 34
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Stealth Peptides Inc., 2014* 35
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Prolong Pharmaceuticals, 2014* 36
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Minapharm Pharmaceuticals & Chemical Industries, 2014* 37
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ischemix, 2014* 38
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Catalyst Biosciences, Inc., 2014* 39
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 40
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Apeptico Forschung und Entwicklung GmbH, 2014* 41
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014* 42
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 43
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2014* 44
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Clinico Humanitas, 2014* 45
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 46
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Regina Elena Cancer Institute, 2014* 47
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by South Australian Health and Medical Research Institute, 2014* 48
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2014* 49
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 50
Ischemia Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014* 51

Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Ischemia Reperfusion Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Ischemia Reperfusion Injury to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Ischemia Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Ischemia Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Ischemia Reperfusion Injury to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Ischemia Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Ischemia Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Ischemia Reperfusion Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Ischemia Reperfusion Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Ischemia Reperfusion Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 70